Automated Breast Ultrasound Systems (ABUS) Market, By Region (North America, Latin America, Europe, Asia Pacific, Middle East, Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published In : Dec 2019

Code : CMI78

Pages :80

Formats :

Excel and PDF

Industry : Medical Devices

Market Challenges And Opportunities

Global Automated Breast Ultrasound System (ABUS) Market: Drivers

Increasing prevalence of breast cancer is a major factor boosting growth of the global automated breast ultrasound system (ABUS) market over the forecast period. For instance, according to the World Health Organization, 2.1 million women worldwide suffer from breast cancer, annually. Moreover, in 2018, 627,000 women died from breast cancer worldwide.

Increasing initiatives of government and private organizations to spread breast cancer awareness is also expected to fuel growth of the market. For instance, in December 2019, AMMETLIFE Insurance Bhd launched a fundraising campaign to support breast cancer awareness programs undertaken by the Pink Ribbon Wellness (L) Foundation.

Global Automated Breast Ultrasound System (ABUS) Market: Restraints

Stringent regulations in various countries have restricted the use of automated breast ultrasound imaging techniques. Moreover, high cost of ultrasound systems compared to conventional cancer screening systems is also expected to hinder growth of the global automated breast ultrasound system (ABUS) market. For instance, on average, a new ABUS can cost around US$ 300,000.

Although ultrasound is quick and can boost cancer detection, it is also prone to false-positive biopsies, which is also expected to hamper growth of the market.

Global Automated Breast Ultrasound System (ABUS) Market: Opportunities

Increasing demand for early diagnosis and treatment of breast cancer is expected to offer lucrative growth opportunities for players in the global automated breast ultrasound system (ABUS) market. According to National Center for Biotechnology Information (NCBI) statistics, women aged 30–34 years may be responsible for a 130.6% increase in incidence of breast cancer by 2025.

Moreover, key players in the market can also focus on integrating full-field digital mammography (FFDM) with ABUS to develop a single platform that can offer improved quality images.